Ballicules › Drugs › Corticotropin
Mechanism of action: Corticotropin ballicule
What it is Repository ACTH gel stimulating adrenal cortisol production; infantile spasms, MS relapses, and inflammatory disease.
Why this one Its strongest niche is infantile spasms, where a finite hormonal course can rapidly suppress the epileptic syndrome.
What limits it Extreme cost and reliance on an intact adrenal axis limit use; hypertension, hyperglycemia, and immunosuppression remain.
Molecular structure: Corticotropin
FDA-approved for
infantile spasms (2010) multiple sclerosis relapses various inflammatory and rheumatic conditions
Off-label
refractory epilepsies beyond infantile spasms
Principal risk Extreme cost; it needs an intact adrenal axis
Classes and tags
Clinical profile
Therapeutic safety burden 2 / 4
Overdose danger 1 / 4
Weight-gain liability 0 / 4
Sedation liability 0 / 4
QT / Torsades 0 / 4
Direct muscarinic antagonism 0 / 4
Embryofetal risk 2 / 4
Legacy pregnancy category Unknown / historical label unavailable
Defining liability Generally tolerated at therapeutic doses; clinically important risks are agent-specific and increase with interactions or organ impairment.
FDA label
Read the full label on DailyMed ↗
FDA dosing Population Start Target Max
Infantile spasms Infants/children <2 y 150 U/m² per day IM (75 U/m² BID) ×2 wk, then taper over 2 wk 150 U/m²/day IM 150 U/m²/day
Acute exacerbations of multiple sclerosis Adults 80–120 U/day IM or SC ×2–3 wk 80–120 U/day 120 U/day
Other disorders/diseases Adults 40–80 U IM or SC q24–72h 40–80 U q24–72h 80 U
Renal Undefined
Hepatic May have enhanced effect in liver cirrhosis; monitor
Instructions Taper dose to avoid adrenal insufficiency after prolonged therapy Infantile spasms must be given IM using the vial; suggested taper: 30 U/m² AM ×3 d, 15 U/m² AM ×3 d, 10 U/m² AM ×3 d, then 10 U/m² every other AM ×6 d SelfJect pre-filled injector is SC, adults only, for single 40 U or 80 U doses
Available strengths
Contraindications Intravenous administration Infants under 2 years with suspected congenital infections Concomitant live or live-attenuated vaccines in patients on immunosuppressive doses Scleroderma, osteoporosis, systemic fungal infections, ocular herpes simplex Recent surgery; history of or present peptic ulcer Congestive heart failure; uncontrolled hypertension Primary adrenocortical insufficiency or adrenocortical hyperfunction Sensitivity to proteins of porcine origin
Cautions Increased susceptibility to/masking of infections Adrenal insufficiency after prolonged therapy withdrawal; Cushing's syndrome Elevated blood pressure, salt/water retention, hypokalemia GI perforation and bleeding Behavioral/mood disturbances (euphoria, insomnia, psychosis, depression) Ophthalmic effects (cataracts, glaucoma); decreased bone density; growth suppression in children
Adverse reactions Injection site reactions Fatigue/malaise/asthenia Fluid retention/peripheral swelling Insomnia, headache, increased blood glucose (Infantile spasms) infections, convulsions, hypertension, irritability, pyrexia
Pregnancy May cause fetal harm via steroidogenic effect; hypoadrenalism reported in infants; observe newborns
Lactation No data on presence in human milk; weigh benefit vs risk
Cost Corticotropin (ACTHAR GEL)
Strength #/mo generic $/unit CostPlus 80 units/mL inj per unit not offered
NADAC is a voluntary CMS survey of what retail community pharmacies pay for the drugs they stock. Corticotropin is administered under clinical supervision and dispensed outside retail pharmacies, so it rarely appears on surveyed invoices.
Generic entry 1984
Open Corticotropin in the interactive console ↗
Self-check Which intact hormonal system is needed for corticotropin to work? Adrenal axis.What is corticotropin’s strongest stated clinical niche? Infantile spasms.